ArticleHealth science reports2025
Irregular Pulse and Cardiovascular Disease From NHANES (1999-2018): A Cross-Sectional Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Pulse is an easily accessible life sign, while irregular pulse could be easily detected in daily life during blood pressure test. However, whether irregular pulse was associated with cardiovascular disease (CVD) or mortality has not been reported on a large population scale. Here, we investigated the association between irregular pulse, CVD, and CVD mortality, to explore the potential of irregular pulse as screening indicator for CVD and mortality, thus influencing health policy. Methods: This cohort study used National Health and Nutrition Examination Survey data from 1999 through 2018 and linked mortality information until 2019. Eligible participants were adults with valid records of self-report CVD and pulse characteristics. Results: We included data from 49,681 participants in the analysis. Compared with regular pulse group, irregular pulse group demonstrated an increased risk of CVD (1.34, [1.14, 1.58]), especially heart failure (1.75, [1.37, 2.24]) and coronary heart disease (1.27, [1.01, 1.60]). Irregular pulse group showed an increased risk for all-cause mortality (HR 1.29, [95% CI, 1.17-1.42]) and CVD mortality (HR 1.53, [95% CI, 1.30-1.81]) compared with regular pulse group. The findings suggest that irregular pulse was associated with CVD and mortality. Participants with irregular pulse were associated with a significantly increased risk of all-cause mortality (HR 1.29, 95% CI [1.17, 1.42], Conclusion: Our study found that people with irregular pulse have a higher incidence of cardiovascular disease and cardiovascular disease mortality than people with regular pulse. These findings highlight the importance of health screening and risk management for people with irregular pulse.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.